blackthornrx.comHealthcareFounded: 2015Funding to Date: $130.3MM
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted medicines for the treatment of central nervous system (CNS) disorders.
View Enterprise Value for Blackthorn Therapeutics.